GUJARAT THEMIS BIOSYN
Back to Cashflow Statement
|
GUJARAT THEMIS BIOSYN Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹115 Cr | ₹26 Cr | ₹-8.59 Cr | ₹-13 Cr | ₹-14 Cr |
What is the latest Cash Flow from Financing Activities ratio of GUJARAT THEMIS BIOSYN ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹115 Cr |
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹-8.59 Cr |
| Mar2023 | ₹-13 Cr |
| Mar2022 | ₹-14 Cr |
How is Cash Flow from Financing Activities of GUJARAT THEMIS BIOSYN Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹115 Cr | 341.79 | |
| Mar2025 | ₹26 Cr | Positive | |
| Mar2024 | ₹-8.59 Cr | Negative | |
| Mar2023 | ₹-13 Cr | Negative | |
| Mar2022 | ₹-14 Cr | - | |
Compare Cash Flow from Financing Activities of peers of GUJARAT THEMIS BIOSYN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GUJARAT THEMIS BIOSYN | ₹5,568.0 Cr | 1% | 15.2% | 11.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
GUJARAT THEMIS BIOSYN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GUJARAT THEMIS BIOSYN | 1% |
15.2% |
11.3% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses